CVE:SVA

Sernova Competitors

C$1.44
-0.03 (-2.04 %)
(As of 04/22/2021 01:32 PM ET)
Add
Compare
Today's Range
C$1.44
Now: C$1.44
C$1.48
50-Day Range
C$1.24
MA: C$1.48
C$1.68
52-Week Range
C$0.14
Now: C$1.44
C$2.87
Volume133,739 shs
Average Volume1.52 million shs
Market CapitalizationC$361.41 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Sernova (CVE:SVA) Vs. LXG, SQD, GEN, LMD, VPT, and IDL

Should you be buying SVA stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Sernova, including LexaGene (LXG), SQI Diagnostics (SQD), GeneNews (GEN), LED Medical Diagnostics (LMD), VentriPoint Diagnostics (VPT), and Imaging Dynamics (IDL).

Sernova (CVE:SVA) and LexaGene (CVE:LXG) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.

Profitability

This table compares Sernova and LexaGene's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SernovaN/AN/AN/A
LexaGeneN/AN/AN/A

Earnings and Valuation

This table compares Sernova and LexaGene's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/AN/AC($0.03)-53.33
LexaGeneN/AN/AN/AC($0.12)-5.97

Sernova is trading at a lower price-to-earnings ratio than LexaGene, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for Sernova and LexaGene, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sernova0000N/A
LexaGene0000N/A

Sernova (CVE:SVA) and SQI Diagnostics (CVE:SQD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.

Profitability

This table compares Sernova and SQI Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SernovaN/AN/AN/A
SQI DiagnosticsN/AN/AN/A

Earnings and Valuation

This table compares Sernova and SQI Diagnostics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/AN/AC($0.03)-53.33
SQI DiagnosticsC$977,000.0099.38C$-12,264,984.00C($0.04)-7.92

Sernova has higher earnings, but lower revenue than SQI Diagnostics. Sernova is trading at a lower price-to-earnings ratio than SQI Diagnostics, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for Sernova and SQI Diagnostics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sernova0000N/A
SQI Diagnostics0000N/A

Summary

SQI Diagnostics beats Sernova on 2 of the 3 factors compared between the two stocks.

Sernova (CVE:SVA) and GeneNews (TSE:GEN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.

Profitability

This table compares Sernova and GeneNews' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SernovaN/AN/AN/A
GeneNewsN/AN/AN/A

Earnings and Valuation

This table compares Sernova and GeneNews' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/AN/AC($0.03)-53.33
GeneNewsC$234,592.000.00C$-11,557,484.00C($0.07)N/A

Sernova has higher earnings, but lower revenue than GeneNews. Sernova is trading at a lower price-to-earnings ratio than GeneNews, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for Sernova and GeneNews, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sernova0000N/A
GeneNews0000N/A

Summary

GeneNews beats Sernova on 2 of the 3 factors compared between the two stocks.

Sernova (CVE:SVA) and LED Medical Diagnostics (CVE:LMD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.

Profitability

This table compares Sernova and LED Medical Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SernovaN/AN/AN/A
LED Medical DiagnosticsN/AN/AN/A

Earnings and Valuation

This table compares Sernova and LED Medical Diagnostics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/AN/AC($0.03)-53.33
LED Medical DiagnosticsC$14.96 million1.04C$-1,512,615.00C($0.04)-10.26

Sernova has higher earnings, but lower revenue than LED Medical Diagnostics. Sernova is trading at a lower price-to-earnings ratio than LED Medical Diagnostics, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for Sernova and LED Medical Diagnostics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sernova0000N/A
LED Medical Diagnostics0000N/A

Summary

LED Medical Diagnostics beats Sernova on 2 of the 3 factors compared between the two stocks.

Sernova (CVE:SVA) and VentriPoint Diagnostics (CVE:VPT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.

Profitability

This table compares Sernova and VentriPoint Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SernovaN/AN/AN/A
VentriPoint DiagnosticsN/AN/AN/A

Earnings and Valuation

This table compares Sernova and VentriPoint Diagnostics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/AN/AC($0.03)-53.33
VentriPoint DiagnosticsC$37,517.001,800.58C$-4,128,201.00C($0.03)-16.36

Sernova has higher earnings, but lower revenue than VentriPoint Diagnostics. Sernova is trading at a lower price-to-earnings ratio than VentriPoint Diagnostics, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations for Sernova and VentriPoint Diagnostics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sernova0000N/A
VentriPoint Diagnostics0000N/A

Summary

VentriPoint Diagnostics beats Sernova on 2 of the 3 factors compared between the two stocks.

Sernova (CVE:SVA) and Imaging Dynamics (CVE:IDL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Profitability

This table compares Sernova and Imaging Dynamics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SernovaN/AN/AN/A
Imaging DynamicsN/AN/AN/A

Valuation and Earnings

This table compares Sernova and Imaging Dynamics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/AN/AC($0.03)-53.33
Imaging DynamicsC$378,253.0040.98C$-3,927,129.00C($0.02)-3.95

Sernova has higher earnings, but lower revenue than Imaging Dynamics. Sernova is trading at a lower price-to-earnings ratio than Imaging Dynamics, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Sernova and Imaging Dynamics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sernova0000N/A
Imaging Dynamics0000N/A

Summary

Imaging Dynamics beats Sernova on 3 of the 3 factors compared between the two stocks.


Sernova Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
LXG
LexaGene
0.5$0.71-0.0%C$83.27 millionN/A-5.97Gap Down
SQD
SQI Diagnostics
0.9$0.29-1.8%C$52.59 millionC$977,000.00-7.92Gap Up
GEN
GeneNews
0.5N/AN/AC$24.65 millionC$234,592.00-2.21
LMD
LED Medical Diagnostics
0.4$0.40-100.0%C$15.51 millionC$14.96 million-10.26Gap Down
VPT
VentriPoint Diagnostics
0.6$0.54-1.9%C$5.58 millionC$37,517.00-16.36
IDL
Imaging Dynamics
0.4$0.08-13.3%C$4.13 millionC$378,253.00-3.95Gap Down
DXD
3D Signatures
0.5$0.04-100.0%C$2.66 millionN/A-0.91Gap Down
MBI
Med Biogene
0.5$0.05-22.2%C$795,000.00N/A-7.50Gap Up
BUX
(BUX)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
IME
12144
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
CRL
Charles River Laboratories International
0.5N/AN/A$0.00N/A0.00Gap Up
SENS
Senseonics
0.0N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 4/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.